Danaher Co. (NYSE:DHR) Shares Acquired by True North Advisors LLC

True North Advisors LLC lifted its position in Danaher Co. (NYSE:DHR) by 70.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,720 shares of the conglomerate’s stock after purchasing an additional 713 shares during the quarter. True North Advisors LLC’s holdings in Danaher were worth $395,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC boosted its stake in Danaher by 1.7% during the 4th quarter. Janney Montgomery Scott LLC now owns 184,484 shares of the conglomerate’s stock worth $42,349,000 after purchasing an additional 3,161 shares during the period. Daymark Wealth Partners LLC increased its stake in Danaher by 0.9% in the 4th quarter. Daymark Wealth Partners LLC now owns 17,521 shares of the conglomerate’s stock valued at $4,022,000 after buying an additional 155 shares during the period. Albion Financial Group UT raised its position in Danaher by 360.7% during the 4th quarter. Albion Financial Group UT now owns 1,290 shares of the conglomerate’s stock worth $296,000 after buying an additional 1,010 shares during the last quarter. Beaumont Financial Advisors LLC lifted its stake in shares of Danaher by 59.4% in the 4th quarter. Beaumont Financial Advisors LLC now owns 2,958 shares of the conglomerate’s stock worth $679,000 after acquiring an additional 1,102 shares during the period. Finally, Bourgeon Capital Management LLC boosted its holdings in shares of Danaher by 7.4% in the fourth quarter. Bourgeon Capital Management LLC now owns 60,178 shares of the conglomerate’s stock valued at $13,814,000 after acquiring an additional 4,150 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on DHR. Evercore ISI increased their price target on shares of Danaher from $275.00 to $278.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. Guggenheim assumed coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. Raymond James dropped their price objective on Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a report on Tuesday. TD Cowen raised their target price on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Robert W. Baird lowered their price target on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $285.55.

Danaher Stock Performance

Danaher stock opened at $244.19 on Thursday. The stock has a fifty day moving average price of $234.84 and a 200 day moving average price of $253.53. Danaher Co. has a 52 week low of $225.42 and a 52 week high of $281.70. The firm has a market capitalization of $176.38 billion, a P/E ratio of 46.60, a PEG ratio of 4.43 and a beta of 0.83. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same period in the prior year, the firm posted $2.02 EPS. The company’s revenue was up 3.1% on a year-over-year basis. Equities research analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.